I believe now the street will also start raising a more realistic "sale" value of Xerecept. Being that NTII owns a big part of that drug, we should continue to see our stock price rise nicely. I was holding on for .25/share....could be a lot more now that this news is out. GL
the risk reward ratio at this price still seems great. Seems as if lots of the longs are just being patient, however it would be nice to see more buying enthusiasm. I guess their is nothing to trigger this stock going onto peoples radar screen to spur buying. My 400,000 shares went from a regular account to roth account at .06 hoping to hit the big capital gain.